Identification of Inappropriate Drug Prescribing by Computerized, Retrospective DUR Screening in Korea

Yeom, Jong Hum; Park, Ji Sun; Oh, Ock-Hee; Shin, Hyun Taek; Oh, Jung Mi

doi:10.1345/aph.1e674

Cited by 9 publications

(6 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…hospital systems for screening and data collection. 5,6,[12][13][14] An intranet portal for recording interventions similar to the intervention portion of MUET has also been developed. 15 Many of these tools entail a two-step process involving manual collection of information on a form followed by data entry into a database for analysis.…”

Section: Discussionmentioning

confidence: 99%

“…This is consistent with the substantial front-end work needed to translate managed care claims data into useful medication-use data. [4][5][6] Pharmacovigilance and surveillance efforts make use of these databases to monitor exposure rates and suspected adverse events. Once an adverse-event signal is identified and confirmed using pharmacoepidemiologic methods, an intervention Am J Health-Syst Pharm-Vol 70 Dec 15, 2013 program to minimize exposure of patients to the identified risk can be developed; the goal of this riskreduction step is to change practices that might adversely affect individual patients.…”

Section: Frameworkmentioning

confidence: 99%

See 1 more Smart Citation

Medication-use evaluation with a Web application

Burk

Moore

Glassman

et al. 2013

American Journal of Health-System Pharmacy

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Frameworkmentioning

confidence: 99%

Medication-use evaluation with a Web application

Burk

Moore

Glassman

et al. 2013

American Journal of Health-System Pharmacy

View full text Add to dashboard Cite

show abstract

“…The latest findings encourage the need of greater supervision over these age groups, using special programs of pharmacotherapeutic follow up [6,[11][12][13][14].…”

Section: Discussionmentioning

confidence: 99%

“…There is a clear bidimensional problem on the use of drugs, since the utilization of resources is involved and, on the other hand, it may generate an increase of risk among the population, which could easily cause a raise in the cost of morbidity and mortality [8,10,12,13].…”

Section: Discussionmentioning

confidence: 99%

Determination of the Frequency and Direct Cost of the Adverse Drug Events in Argentina

Izquierdo

Rodriguez²,

Pampliega³

et al. 2009

CDS

View full text Add to dashboard Cite

To determine the frequency and the direct costs of adverse drug reactions, in an ambulatory population of the City of Buenos Aires, Argentina and its area of influence. A retrospective study was done during a period of three months on approximately 300.000 residents of the Buenos Aires area, gathering data according to the selected variables by means of the electronic capture of prescriptions dispensed in pharmacies of the area. This method enables the detection and registration of potential conflicts that may arise between a prescribed drug and factors such as: patient's demographic, clinical and drug profile. The analysis unit was defined as the happening of a moderate or severe adverse event reported by the system. The selected variables were the incidence of these effects and the direct cost was calculated as the value of the drugs that induced the adverse event. The events were classified according to the following interactions: a) drug-drug, b) drug-pediatrics, c) drug-gender, d) drug-pregnancy and abuse of controlled substances. The observed frequency shows great variability and the shortage of available data for ambulatory populations. We found 6.74% of reported events over the total of processed items, which generated an additional cost equivalent to 4.58% of the total pharmaceutical expenses. This study has only evaluated the cost occurred by the use of a drug that will lead to an adverse reaction. Moderate and severe reactions were included regardless of the important indirect costs, hospitalization costs, tests, physician fees, etc.

show abstract

“…Due to the serious health risks, some drugs are contraindicated based on the age of the patient but are still used . The incidence of contraindicated drug prescribing in Korea was reported to be high in 2005: 10.4% of prescriptions showed a conflict with at least one of the drug utilization review (DUR) standards, and age‐specific contraindications accounted for 7% of the total DUR conflicts …”

mentioning

confidence: 99%